Maria Rosaria Valerio
Overview
Explore the profile of Maria Rosaria Valerio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
892
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valerio M, Scandurra G, Greco M, Gebbia V, Piazza D, Sambataro D
In Vivo
. 2025 Feb;
39(2):1000-1008.
PMID: 40010972
Background/aim: A high percentage of cancer patients use complementary therapies (CM) during their disease journey. Several barriers for CM prescription still exist among oncologists. This study explored oncologists' attitudes toward...
2.
Sambataro D, Gebbia V, Bonasera A, Quattrocchi A, Caputo G, Vinci E, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941769
Background: Brain metastases (BMs) from endometrial cancer (EC) are rare and challenging to treat, with limited standardized guidelines. This systematic review aims to evaluate the incidence, therapeutic strategies, and outcomes...
3.
Colombo A, Concetta P, Gebbia V, Sambataro D, Scandurra G, Valerio M
In Vivo
. 2024 Dec;
39(1):25-36.
PMID: 39740863
Patients affected by metastatic carcinoma of the colon/rectum (mCRC) harboring mutations in the BRAF gene (MBRAF) respond poorly to conventional therapy and have a prognosis worse than that of patients...
4.
Cipolla C, Gebbia V, DAgati E, Greco M, Mesi C, Scandurra G, et al.
Curr Oncol
. 2024 Dec;
31(12):7566-7574.
PMID: 39727680
Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer cases. Sentinel lymph node biopsy (SLNB) has emerged as a less invasive alternative...
5.
Krasniqi E, Filomeno L, Arcuri T, Di Lisa F, Astone A, Cutigni C, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682290
Background/objectives: HER2-positive breast cancer (HER2BC) is an aggressive subtype, with neoadjuvant treatment (NAT) aiming to achieve a pathological complete response (pCR) to improve long-term outcomes. Trastuzumab emtansine (T-DM1) has been...
6.
Valerio M, Gebbia V, Piazza D, Campisi G, DAgati E, Bazzano M
Case Rep Oncol
. 2024 Oct;
17(1):1174-1182.
PMID: 39474558
Introduction: Metastatic breast cancer (MBC) presents an enduring and significant challenge for affected women, requiring sustained commitment over the years. Case Presentation: This paper presents a case of a woman...
7.
Scandurra G, Sambataro D, Gebbia V, Piazza D, Valerio M
J Cancer Educ
. 2024 Oct;
PMID: 39425870
Herpes zoster (HZ) virus reactivation is a significant medical problem among immunocompromised patients, especially considering its potential complications. Although the recombinant HZ vaccine has demonstrated > 90% efficacy against HZ...
8.
Cipolla C, Gebbia V, DAgati E, Greco M, Mesi C, Scandurra G, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409973
Background: In breast cancer (BC) patients, axillary management has undergone major improvements over the last few years, and efforts to identify the optimal strategy for the management of axillary surgery...
9.
Lavalle S, Masiello E, Valerio M, Aliprandi A, Scandurra G, Gebbia V, et al.
Exp Ther Med
. 2024 Aug;
28(4):381.
PMID: 39113908
Immune checkpoint inhibitor (ICI) therapy has revolutionized cancer treatment by enhancing the immune response against tumor cells. However, their influence on immune pathways can lead to immune-related adverse events such...
10.
Scandurra G, Lombardo V, Scibilia G, Sambataro D, Gebbia V, Scollo P, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001528
Brain metastases (BM) pose a significant challenge in the management of HER2+ breast cancer since almost 50% of patients with HER2+ breast cancer develop brain tumors. The complex process of...